NEWS

Alliance Group Statistician Co-Chairs Working Group Whose Recommendations Define a "New Normal" for Data Collection and Published in the Journal of the National Cancer Institute

October 29, 2024

The Journal of the National Cancer Institute has published ‘Streamlining the Conduct of Cancer Clinical Trials: New Standard Data Collection Practices for National Cancer Institute Late Phase Clinical Studies,’ which assesses the impact of the stressors on


MyeloMATCH Precision Medicine Trials in Myeloid Leukemias Open to Patient Enrollment Across the U.S. and Canada

October 23, 2024

Umbrella trial design will link multiple NCI-supported studies to allow patients with newly diagnosed acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) to register to clinical trials throughout the course of their cancer treatment.

Four leading cancer research organizations in the United States and Canada announce the opening of patient enro


2024 Alliance Fall Hybrid Group Meeting Convenes October 30-November 1

October 23, 2024
























Meeting book

Congratulations to the Memorial Sloan Kettering Cancer Center (MSK) for the 2024 Alliance Fall Hybrid Group Meeting Book cover design. Darren Feldman, MD, is the Principal Investigator of the NCTN LAPS Grant. For more than three decades, U.S. News & World Report has consistently recognized MSK as one of t


Older News